From Platform to Patient: Defining Market Readiness for Genetic Medicines
A 1-day workshop co-hosted by ARM and GenoTher.
ARM unites the cell and gene therapy ecosystem to modernize healthcare systems, overcome obstacles to innovation, and improve patient access to life-changing treatments.
ARM is where the CGT sector converges to solve its most pressing challenges. We unite a multistakeholder community of biotechnology companies, research institutions, patient advocates, and strategic suppliers to shape regulation and policy, unlock access, and accelerate transformative therapies.
Learn More About ARMWe support our members in advancing living medicines that target the root causes of disease—therapies that repair or replace cells and genes to durably treat and potentially cure a wide range of conditions.
Our data and reports track the global pipeline, clinical trials, regulatory shifts, and funding trends, giving the CGT community and our stakeholders the insight needed to make informed, strategic decisions.
These policies, which became law with President Trump’s signature, represent hope for the rare disease community and will meaningfully improve access to life-changing and life-saving treatments.
We applaud Congress for passing ARM’s top two legislative priorities and are grateful to our partner organizations whose collaboration and advocacy were crucial in securing the necessary support.
Join a global community collaborating to shape the future of CGT through advocacy, networking, and scientific engagement. Together, we have the power to advance the sector and improve patients' lives.
Participate in forums and advisory groups that develop positions on scientific, regulatory, access, and reimbursement policies.
Engage with the community via ARM’s member portal, events, workshops, and working groups to build strategic relationships across the CGT sector.
Access exclusive investor relations tools and attend member-only webinars and events to strengthen your relationship with investors.
Elevate your visibility in the CGT community through sponsorship and networking opportunities and member-exclusive speaking and leadership roles.
member organizations
industry professionals
countries represented
Curated reports and frameworks to help you identify trends and navigate CGT’s biggest technical and policy challenges.
Explore the Q1 trends in CGT funding, approvals, pipeline trends, and policy shifts shaping the global landscape.
A strategic framework for identifying, characterizing, and mitigating impurities across therapeutic cell types.
Sign up for ARM’s weekly newsletter on sector news and alerts for events, reports, and other engagement opportunities.